Butalbital, Aspirin, Caffeine and Codeine Phosphate - Butalbital, Aspirin, Caffeine and Codeine Phosphate
Navigation: NDC > Supplier starting with: W > WATSON LABORATORIES, INC.| Field | Value |
|---|---|
| NDC Code: | 0591-3546 |
| Proprietary Name: | Butalbital, Aspirin, Caffeine and Codeine Phosphate |
| Suffix: | |
| Non-Proprietary Name: | Butalbital, Aspirin, Caffeine and Codeine Phosphate |
| Dosage Form: | CAPSULE |
| Method: | ORAL |
| Original Marketing Date: | 12-07-2007 |
| Category Name: | NDA AUTHORIZED GENERIC |
| Application Number: | NDA019429 |
| Labeler: | WATSON LABORATORIES, INC. |
| Substance Name: | ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE |
| Active Numerator Strength: | 325; 50; 40; 30 |
| Active Ingredient Unit: | mg/1; mg/1; mg/1; mg/1 |
| Pharm Classes: | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| DEA Schedule: | CIII |